NCT06149767 2023-11-29Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical CancerFujian Cancer HospitalPhase 2 Not yet recruiting26 enrolled
NCT06078670 2023-10-12PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid TumorsFujian Cancer HospitalPhase 1/2 Not yet recruiting96 enrolled